Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea

被引：0

作者：

Kim, David ^{[1
]}

Lee, Jae Seung ^{[1
]}

Chun, Ho Soo ^{[1
]}

Lee, Hye Won ^{[1
]}

Kim, Beom Kyung ^{[1
]}

Park, Jun Yong ^{[1
]}

Kim, Do Young ^{[1
]}

Han, Kwang-Hyub ^{[1
]}

Lee, Yu Rim ^{[2
]}

Tak, Won Young ^{[2
]}

Kweon, Young Oh ^{[2
]}

Ahn, Sang Hoon ^{[1
]}

Kim, Seung Up ^{[1
]}

机构：

[1] Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea

[2] Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT454

引用

页码：S880 / S880

页数：1

共 50 条

[31] Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis
Yuan, Peng
Chen, Peng
Qian, Yeben
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 2016
[32] Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
Wang, Kai
Jiang, Guomin
Jia, Zhongzhi
Zhu, Xiaoli
Ni, Caifang
MEDICINE, 2018, 97 (22)
[33] Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria
Zhang, Yiheng
Liu, Xu
Li, Shu
Lin, Chunlei
Ye, Qian
Wang, Yuying
Wu, Juanli
Zhang, Yushuang
Gao, Han
Li, Tao
Qu, Yundong
Wang, Yan
HEPATOLOGY COMMUNICATIONS, 2024, 8 (01)
[34] Baseline FIB-4 May Be a Risk Factor of Recurrence After SBRT in Patients With HBV-Related Small HCC
Zeng, Zhan
Han, Yifan
Li, Wengang
Chen, Hongyu
Lin, Ning
Yu, Yanyan
Xu, Xiaoyuan
CANCER MEDICINE, 2025, 14 (01):
[35] Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
Kim, David Sooik
Park, Soo Young
Kim, Beom Kyung
Park, Jun Yong
Kim, Do Young
Han, Kwang-Hyub
Lee, Yu Rim
Tak, Won Young
Kweon, Young Oh
Jung, Inkyung
Han, Minkyung
Kim, Eun Hwa
Ahn, Sang Hoon
Kim, Seung Up
JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (16) : e105
[36] ANTIVIRAL THERAPY REDUCES HEPATOCELLULAR CARCINOMA RISK AMONG HBV PATIENTS IN THE INDETERMINATE PHASE
Huang, Daniel
Tran, Andrew Khoa
Yeh, Ming-Lun
Tsai, Pei-Chien
Chuang, Wan-Long
Huang, Chung-Feng
Dai, Chia-Yen
Toyoda, Hidenori
Yasuda, Satoshi
Trinh, Huy
Ogawa, Eiichi
Ishigami, Masatoshi
Ito, Takanori
Kozuka, Ritsuzo
Enomoto, Masaru
Tanaka, Yasuhito
Suzuki, Takanori
Yoshimaru, Yoko
Preda, Carmen
Marin, Raluca
Sandra, Irina
Quek, Sabrina
Khine, Htet Htet Toe Wai
Itokawa, Norio
Atsukawa, Masanori
Uojima, Haruki
Watanabe, Tsunamasa
Takahashi, Hirokazu
Inoue, Kaori
Maeda, Mayumi
Hoang, Joseph
Trinh, Lindsey
Cheung, Ramsey
Lim, Seng Gee
Yu, Ming-Lung
Nguyen, Mindie H.
HEPATOLOGY, 2022, 76 : S34 - S35
[37] THE RISK OF HEPATITIS B-RELATED HEPATOCELLULAR CARCINOMA (HCC) IS REDUCED WITH ANTIVIRAL THERAPY: EVIDENCE FROM 3 HCC PREDICTION MODELS
Abu-Amara, M.
Cerecchi, O.
Mahli, G.
Sharma, S.
Yim, C.
Shah, H.
Wong, D. K.
Janssen, H. L. A.
Feld, J. J.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S130 - S131
[38] Comment on "Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis"
Mo, Han-Yue
Xiang, Bang-De
Zhong, Jian-Hong
Li, Le-Qun
You, Xue-Mei
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 2016
[39] Prophylactic Antiviral Therapy Before Hepatectomy Is Beneficial to HBV-Related Hepatocellular Carcinoma Patients with Negative HBV-DNA: Comments on Statistical Analysis of the Study
Ramakrishna, H. K.
INDIAN JOURNAL OF SURGERY, 2022, 84 (05) : 1136 - 1137
[40] Prophylactic Antiviral Therapy Before Hepatectomy Is Beneficial to HBV-Related Hepatocellular Carcinoma Patients with Negative HBV-DNA: Comments on Statistical Analysis of the Study
Ramakrishna HK
Indian Journal of Surgery, 2022, 84 : 1136 - 1137

← 1 2 3 4 5 →